skinny.

Latest / Driving the Business of Science

AI in Clinical Trials. A Scientist's Perspective.

Send us Fan Mail

Keith Parent, CEO of Court Square Group, discusses the intersection of science and business in drug development with Dr. Joseph Geraci, Founder, Chief Scientific and Technical Officer of NetraMark. Dr. Geraci, with a background in mathematics and AI, focuses on understanding patient populations and improving clinical trials. He explains how NetraMark's AI technology can analyze small, complex data sets to identify treatment and placebo responder subpopulations and improve drug efficacy. Dr. Geraci emphasizes the potential of adaptive trials and the importance of personalized…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.